Zynerba Pharmaceuticals Aktie

18,12 $ +0,06% +0,01 $
In Euro: 16,930 € | 20.01.17 Nasdaq | Mehr Kurse »
WKN: A14XCV
ISIN: US98986X1090
Symbol: ZYNE
Typ: Aktie

Performance Zynerba Pharmaceuticals Aktie

1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 18,69 $ 14,66 $ 11,96 $ 15,59 $ 9,40 $ -
Änderung -3,05% +23,60% +51,51% +16,23% +92,77% -

Forum zur Zynerba Pharmaceuticals Aktie

chinasky: DEA: "CBD" a schedule I substance ! in US
19.12.16
Zitat:"On Dec. 14, 2016, the United States Drug Enforcement Administration announced a new rule that makes hemp-​based cannabidiol a federally illegal substance. Under the new rules, liquid extracts derived from plants of the cannabis genus that contain one or more ...

Analysen

Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

Aktie & Unternehmen

Branche Pharmazeutik
Herkunft USA
Website www.zynerba.com
Aktienanzahl 9,95 Mio. (Stand: 10.01.17)
Marktkap. 180,4 Mio. $

Dividenden & Splits

Keine Daten im genannten Zeitraum vorhanden

Ähnliche Aktien

Name
last
change_rel
 
KalVista Pharmaceuticals 6,77 € +1,48%
Dipexium Pharmaceuticals 1,45 € +2,55%
Inotek Pharmaceuticals 1,594 € -0,50%
Merrimack Pharmaceuticals 2,771 € -0,79%
Conatus Pharmaceuticals 4,153 € -6,42%